Skip to content

A clinical study for evaluating the efficacy of soft drink containing reduced type of indigestible dextrin on the function of intestinal regulation to subjects having tendency toward constipation. -Randomised double-blind placebo-controlled trial

A clinical study for evaluating the efficacy of soft drink containing reduced type of indigestible dextrin on the function of intestinal regulation to subjects having tendency toward constipation. -Randomised double-blind placebo-controlled trial - A clinical study for evaluating the efficacy of soft drink containing reduced type of indigestible dextrin on the function of intestinal regulation to subjects having tendency toward constipation. -Randomised double-blind placebo-controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000021665
Enrollment
50
Registered
2016-04-02
Start date
2016-04-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Soft drink containing reduced type of indigestible dextrin(5g/serving) (2 weeks), washout(2 weeks), Placebo drink(2 weeks) Placebo drink(2 weeks), washout(2 weeks), Soft drink containing reduced type

Sponsors

KSO Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) (Healthy) subjects aged 20 to 59 years old (2) Subjects having meal 3 times per day (3) Subjects giving written informed consent

Exclusion criteria

Exclusion criteria: (1) Individuals taking antiflatulents and/or laxatives(including purgative drugs) in common use (2) Individuals taking health foods in common use, including food for specified health use, which influence intestinal regulation at the point of screening examination (3) Individuals taking antibiotics and/or drugs which influence laxatives(including purgative drugs) in common use at the point of screening examination (4) Individuals daily consuming alcohol as equivalent amount of sake more than 360ml (5) Individuals who are not able to stop consumption of foods containing lactic acid bacteria, bifidobacteria, natto bacteria, oligosaccharides, dietary fibers, high amount of sugar alcohol and/or other health foods including food for specified health use, which influence intestinal regulation during the study period (6) Individuals presenting known food allergy (7) Individuals who are suffered from a disease which needs treatment urgently or individuals with severe complications (8) Individuals with a digestive organ disease or surgical history who has an influence on digestive absorption and defecation (9) Individuals who are judged to be unsuitable as a subject from an answer of a subjective background questionnaire (10) Individuals who are pregnant or breast-feeding, or have the will of pregnancy during the study period (11) Individuals who are under treatment or have a history of drug/alcohol dependence (12) Individuals who participate in other clinical studies or who are in willing to participate to these studies using foods, drugs and/or cosmetics (13) Individuals who are judged as unsuitable for the study by the investigator for the other reasons

Design outcomes

Primary

MeasureTime frame
Defecation frequency per day, Defecation frequency per week, Fecal amount. Time of assessment: after two-week intake of active/placebo drinks, defecation frequency, defecation frequency and fecal amount are assessed on a weekly basis.

Secondary

MeasureTime frame
Fecal shape, color and odor. Feeling after defecation

Countries

Japan

Contacts

Public ContactYoshika Komori

KSO Corporation Sales department

yoshi@kso.co.jp03-3452-7733

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026